Epigenetics Market size is set to grow by USD 1.47 billion from 2024-2028, Rising epigenetic applications in non-oncology diseases to boost the market growth, Technavio prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
A research team at the University of Tokyo says it has detected accumulations of proteins believed to cause Alzheimer's in blood samples taken from Japanese people with mild or no symptoms, potentially allowing easier and earlier detection of the disease.
Adlai Nortye Ltd. announced that the first patient was dosed in the Phase II clinical trial known as ARTEMIS . This clinical study evaluates palupiprant , a small molecule prostaglandin E receptor 4 .
Biogen CEO Looks for Small Deals While Alzheimer's Drug Ramps Up bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.